Latest Patents

Patents imply intellectual property and it has a $ value that can be associated depending on the field and type of patent that is allocated. Patents also increase the enterprise value of the company and help prevent copy-cats from copying the idea without having royalt payments or licencing deals. We like it when companies get patents awarded!. To protect IP companies aggressively file provisional patents even before they have a working product. The below table provides a way to look at what has been done by companies and use this as a factor to make investment decisions.

     
Title Filing Date Publication Date Grant Date
Lefamulin and its derivatives for use in the treatment of a spiral shaped … 2023-2-07 2023-8-17
Therapeutic use of pleuromutilins 2022-10-12 2022-12-01
Novel 12-epi-mutilin compounds and uses thereof 2022-4-15 2022-10-20
Pleuromutilin derivatives for the treatment of diseases mediated by microbes 2022-3-23 2022-7-14
Siderophore cephalosporin conjugates and uses thereof 2022-3-02 2022-5-01
Therapeutic use of pleuromutilins 2021-4-16 2022-2-01
Novel therapeutic use of pleuromutilins 2021-4-16 2022-2-01
Novel 12-epi-mutilin compounds, process for preparing the same and uses thereof 2021-4-16 2021-11-04
LEFAMOULIN INJECTABLE PHARMACEUTICAL FORMULATIONS 2021-1-13 2022-5-27
Patent LUC00178I2 2020-10-06 2021-12-14
Method for the detection and quantification of fosmomycin, impurities and … 2020-3-10 2020-9-24
Methods of identifying novel dosing regimens 2019-12-12 2023-4-26
Purification of pleuromutilin 2019-8-06 2019-9-26
Methods for Improving Drug Treatments in Mammals 2018-10-02 2019-5-09
Process for the preparation of pleuromutilins 2018-9-27 2019-6-06
Methods for identifying novel dosing regimens 2018-1-09 2021-9-28 2021-9-28
Enantiomerically pure amine 2016-8-05 2017-1-12
12-epi-pleuromutilins 2016-6-26 2016-8-31
Injectable pharmaceutical formulations of lefamulin 2016-6-14 2023-10-03 2023-10-03
Mutilin derivatives and their use as pharmaceuticals 2013-1-21 2013-7-11
Pleuromutilins and process for the preparation of pleuromutilins 2012-10-26 2014-1-07 2014-1-07
Tuberculosis treatment using pleuromutilin derivatives 2011-10-25 2012-2-23
Pleuromutilin derivatives and the use thereof 2011-8-17 2017-11-01 2017-11-01
Organic compounds 2011-7-27 2012-4-05
Process for the preparation of pleuromutilins 2011-5-23 2012-11-22
Pleuromutilin derivatives for the treatment of diseases mediated by microbes. 2010-8-27 2012-2-27
Substituted clavulanic acid 2010-8-12 2015-6-24 2015-6-24
Pleuromutilin derivatives and their use as antimicrobials 2010-5-27 2010-9-10
Antibacterial mutilins 2009-4-07 2009-8-20
Pleuromutilin derivative having antibacterial activity 2008-11-26 2009-5-21
Organic compounds 2008-7-11 2010-4-21
Organic compounds 2006-8-02 2007-10-16
Pleuromutilin derivatives containing a hydroxyamino- or acyloxyaminocycloalkyl … 2006-6-26 2014-9-17 2014-9-17
Organic compounds 2006-6-22 2007-8-16
Pleuromutilin derivatives as antimicrobbials 2005-11-28 2006-3-31
Use of pleuromutilins for the treatment of disorders caused by helicobacter … 2005-7-13 2005-9-30
Acremonic acid derivatives 2004-11-04 2005-6-02
Cephalosporins 2003-7-14 2004-1-22
Crystalline hydrochloride of 7- [(5-amino-1,2,4-thiadiazol-3-yl)( … 2003-1-31 2004-11-10
Formulations pharmaceutiques injectables de lefamuline 2016-6-14 2023-10-03 2023-10-03